“Collaboration between Bosch and Randox brings advanced BioMEMS technology to point-of-care PCR testing, allowing for rapid, automated analysis of hundreds of genetic traits”

Latest Comments
No comments to show.

Tags:

Bosch and Randox Laboratories Ltd. announced a strategic partnership on Wednesday, April 10, 2024. The two companies are set to invest around 150 million euros in joint research, development, and sales activities for new tests for the Vivalytic analysis platform provided by Bosch Healthcare. One of the main goals of this partnership is the development of a sepsis IVD grade (in-vitro diagnostics)…

Source

Categories

No responses yet

Leave a Reply

Your email address will not be published.